DNA RNA and Cells

17 Apr 2009 Osiris Completes Enrollment in Second Prochymal Phase III Trial for Graft vs. Host Disease
15 Apr 2009 Lorus Announces Report of Evidence of Clinical Activity in Clinical Trial of LOR-2040 Combined With Capecitabine and Oxaliplatin in the Treatment of Advanced Metastatic Solid Tumors
08 Apr 2009 Kiadis Pharma Reports ATIR(TM) Clinical Data, Further Supporting its Potential in Mismatched Bone Marrow Transplantations
08 Apr 2009 The Journal of Cardiac Failure Publishes Results From Celladon Corporation's First-in-Human Phase 1/2 Clinical Trial in Advanced Heart Failure
06 Apr 2009 ReNeuron announces positive pre-clinical data with lead stem cell line in peripheral arterial disease
03 Apr 2009 Alnylam Initiates Phase I Clinical Study of ALN-VSP in Patients with Liver Cancer
25 Mar 2009 Tekmira Pharmaceuticals Extends Research Collaboration With Bristol-Myers Squibb Through 2009
24 Mar 2009 Rexahn Pharmaceuticals, Inc. (RNN) Initiates Phase II Pancreatic Cancer Clinical Trial
23 Mar 2009 MDRNA Announces Worldwide Non-Exclusive Licensing Agreement for RNAi Delivery Technology
20 Mar 2009 Another LNA-based RNA Inhibitor Enters Clinical Trials
19 Mar 2009 Enzon Reveals New LNA Targets
17 Mar 2009 Opexa's Stem Cell Therapy for Diabetes Shows Progress
16 Mar 2009 Healthpoint Initiates Phase II, DoseFinding Study to Evaluate Effectiveness of a Unique Cell Based Therapy in Venous Leg Ulcers
09 Mar 2009 Neuralstem's Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
09 Mar 2009 FDA Appeal Decision Indicates that Genasense® Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Trial
06 Mar 2009 Cytori Stem & Regenerative Cell Heart Attack Trial Feasible & Safe
06 Mar 2009 OPKO Health Announces Update on Phase III Clinical Trial of Bevasiranib
05 Mar 2009 Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars
03 Mar 2009 FDA Removes Clinical Hold From Aastrom Phase II IMPACT-DCM Clinical Trial
02 Mar 2009 TissueGene Announces Regulatory Allowance to Initiate Phase IIa Study of TG-C in South Korea for Osteoarthritis of the Knee
02 Mar 2009 Pluristem Therapeutics Receives FDA Clearance to Begin "First-In-Human" Placenta-Derived Stem Cell Clinical Trial
25 Feb 2009 First Group of Heart Failure Patients Treates With "Off-The-Shelf" Adult stem Cells Successfully Pas
23 Feb 2009 MDRNA Successfully Silences Gene Targets in Animal Models Using Novel UsiRNA Constructs
20 Feb 2009 Neuralstem's ALS Trial on Clinical Hold
19 Feb 2009 AVI BioPharma Announces Treatment of First Patient in Systemic Clinical Trial of AVI-4658 for Treatment of Duchenne Muscular Dystrophy

La Merie Biologics

FREE Weekly News Bulletin

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing